Categories

行业新闻

GE Healthcare和Roche合作伙伴开发数字诊断平台

经过Labmedica Internationalstaff writers
2018年1月16日

图像:GE Healthcare和Roche已建立合作伙伴关系,共同开发和共同开发和共同市场数字临床决策解决方案(照片由Istock提供)。GE Healthcare(伊利诺伊州芝加哥)和Roche(瑞士巴塞尔)已经建立了战略性的长期合作伙伴关系,以共同开发和共同开发和共同市场的数字临床决策解决方案。最初,合作伙伴关系将集中在加速和改善癌症和重症监护患者个性化治疗方案的产品上。

GE Healthcare是医疗成像设备的领先提供商,在硬件,软件和生物技术方必威在线客服面利用数据和分析。Roche是药品和诊断的先驱,并且是世界上最大的生物技术公司,在中枢神经系统的肿瘤学,免疫学,传染病,眼科和疾病中提供了差异化的药物。该公司还是体外诊断和基于组织的癌症诊断领域的领导者,并且是糖尿病管理领域的领先者。

Together, the companies will focus on developing the first digital platform in the industry, using advanced analytics to provide workflow solutions and apps that support clinical decisions. This will enable seamless integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real time monitoring and the latest research outcomes. This will also provide comprehensive decision support to clinicians for offering the right treatment and quality of care for their patients.

例如,拥有多名专家的肿瘤学护理团队将能够访问全面的数据仪表板,以审查,协作并保持疾病每个阶段的癌症患者的治疗决策。同样,在重症监护设置中,来自患者医院监测设备的数据将与其生物标志物,基因组和测序数据集成在一起,以帮助医生识别甚至预测严重的并发症。

Roche Diagnostics首席执行官Roland Diggelmann说:“这种独特的伙伴关系将提供创新的解决方案和临床决策的见解。”“我们的目标是通过在正确的时间和全面的数字产品提供正确的决策支持来支持临床医生和其他相关利益相关者,以使患者受益。”

“This is the first time that two major players in healthcare have combined digital, in-vivo and in-vitro diagnostics to this degree,” said Kieran Murphy, President and CEO of GE Healthcare. “We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry.”



E-mail Print
Facebook 推特 Google+ 链接

GE Healthcare

GE Healthcareprovides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
更多信息

More articles about GE Healthcare

29 Apr 2022
GE Healthcare和Medtronic合作,以改善ASC和OBL的产品访问
GE Healthcare(Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
23 Dec 2021
GE Healthcare完成对BK Medical的收购以扩大其超声业务必威在线客服
GE Healthcare(Chicago, IL, USA) has completed its previously announced acquisition of BK Medical (Peabody, MA, USA; www.bkmedical.com) in a deal that would expand its ultrasound business from diagnostics into surgical and therapeutic interventions.
Read More
13 Nov 2021
GE Healthcare将于2023年开发,以在Precision Health的中心创建Pure-Play Company
通用电气(GE;美国马萨诸塞州波士顿)计划在2023年初在Precision Health的中心创建一家Pure-Play公司,从而追求无税的衍生产品。
Read More
2021年9月30日
GE HealthcareAcquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare(Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More
2021年7月26日
GE Healthcare支持创新的全身PET/CT扫描仪的开发,用于同时进行全身成像
GE Healthcare(Chicago, IL, USA) is backing a collaboration among Quibim (Valenciana, Spain), Full Body Insight, and Oncovision (Valenciana, Spain) to build an innovative total-body PET/CT scanner for simultaneous whole-body imaging.
Read More
30 Jan 2020
研究发现,大多数医疗机构计划使用AI并开发自己的AI算法
A new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.
Read More
26 Sep 2019
GE Healthcare和Affibody合作开发PET Imaging Tracers
GE Healthcare和Affibody AB已进行了战略合作,以开发和商业化基于Affibodo的PET Imaging Tracers,最初关注HER2和PD-L1。
Read More
2019年8月22日
GE Healthcare与Fujitsu合作伙伴开发用于发现大脑动脉瘤的AI
GE Healthcare已与澳大利亚富士通进行了一项研究合作,以使用人工智能诊断和监测扫描更快,更有效地对扫描的脑动脉瘤进行诊断和监测。
Read More

Additional news

2022年6月27日
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
鉴于生活方式疾病的发生率越来越大,对负担得起的医疗保健的需求越来越多,使用机器人设备的有效手术会导致治疗成本下降,并推动全球机器人辅助手术器械(RASD)市场的增长。
Read More
2022年6月24日
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
到2031年,全球微创手术(MIS)市场将超过3250亿美元
在2031年患者的意识上,全球MIS市场预计到2031年将超过3250亿美元。
Read More
2022年6月21日
Medix Biochemica获取IVD原材料生产商Bioresource Technology
Medix Biochemica(芬兰ESPOO)已收购了Bioresource Technology(BRT,Weston,FL,USA)的100%股票,以扩大其基本矩阵能力,并进一步增强其在美国市场的本地业务。
Read More
2022年6月21日
全球床头测试市场见证重症监护的前景
在过去的几年中,由于提供临床相关的信息而无需专门的实验室,因此在分析测试中也获得了护理点或使用点的诊断,在分析测试中已提高了突出。
Read More
2022年6月20日
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
在2022 - 2028年期间,全球败血症诊断市场预计将以8.3%的复合年增长率增长,到2028年,由于医院获得的疾病数量的增加以及迅速增长的分子诊断市场,到2028年将近8.8亿美元。尽管自动诊断工具的高成本可能会阻碍市场的增长。
Read More
2022年6月14日
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton,Dickinson and Company(BD,美国新泽西州富兰克林湖)与Mayo Clinic Platform(美国明尼苏达州罗切斯特)进行了合作,以访问Mayo Clinic Platform_discover的DE鉴定的患者数据。
Read More
2022年6月14日
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation(美国加利福尼亚州圣地亚哥)正在与全球莱姆联盟(Stamford,CT,美国)联合起来,以提高莱姆病宣传月(5月)及以后的莱姆病意识月期间围绕莱姆病的公众意识。
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. |条款和条件